Medical comms - Press Releases

Date	Title	Company
31-Jul-2020	Tagrisso granted Breakthrough Therapy Designation in the US for the adjuvant treatment of patients with Stage IB-IIIA EGFR-mutated lung cancer	AstraZeneca
31-Jul-2020	RedHill Biopharma Initiates Global Phase 2/3 Study for COVID-19	RedHill Biopharma
31-Jul-2020	Invitation to the Extraordinary Shareholders’ Meeting	Biocartis Group NV
31-Jul-2020	Oxford Biomedica Signs Three Year Clinical Supply Agreement with Axovant Gene Therapies for Manufacture and Supply of AXO-Lenti-PD	Oxford Biomedica
31-Jul-2020	Sanofi and GSK selected for Operation Warp Speed to supply United States government with 100 million doses of COVID-19 vaccine	Sanofi
31-Jul-2020	BioNTech Announces Strategic Collaboration with Regeneron to Advance FixVac and Libtayo® (cemiplimab) Combination in Melanoma	BioNTech
31-Jul-2020	Combating Coronavirus Through Reversing Diabetes	The Diabetes Reversal Company
31-Jul-2020	Pfizer and BioNTech to Supply Japan with 120 Million Doses of Their BNT162 mRNA-Based Vaccine Candidate	Pfizer Inc
31-Jul-2020	NICE Recommends BAVENCIO® (Avelumab) in Combination with Axitinib for First-Line Treatment of Adult Patients with Advanced Renal Cell Carcinoma	Merck
30-Jul-2020	Chi-Med Reports 2020 Interim Results and Provides Updates on Key Clinical Programs	Chi-Med
30-Jul-2020	Oculis to Present at the LifeSci Partners Private Company Virtual Summer Symposium	Oculis
30-Jul-2020	Evelo Biosciences Reports Second Quarter 2020 Financial Results and Business Highlights	Evelo Biosciences, Inc.
30-Jul-2020	New data in NEJM shows nirsevimab reduced respiratory syncytial virus infections (lower respiratory tract infections) requiring medical care in healthy premature infants	sanofi
30-Jul-2020	GAMA Healthcare Bolsters Science and Innovation Team with Four New Hires	GAMA Healthcare
30-Jul-2020	Sanofi and GSK agree with the UK government to supply up to 60 million doses of COVID-19 vaccine	Sanofi
30-Jul-2020	Scrapping COVID Patents: PM Johnson needs to resist populist calls	Consumer Choice
30-Jul-2020	Biotech Vico Therapeutics raises $31 million (€27 million) in Series A financing round to advance therapies for rare central nervous system diseases	Vico Therapeutics
30-Jul-2020	Acacia Pharma Advances Preparations for US Launch of BARHEMSYS®	Acacia Pharma Group plc
30-Jul-2020	Oculis Announces Successful End-of-Phase 2 Meeting with the FDA for OCS-01 in Two Ophthalmology Indications	Oculis
30-Jul-2020	New clinical study shows heat combined with TENS provides 32% reduction in chronic pain	OMRON Healthcare Europe